Tirzepatide Explained: The Dual-Agonist Peptide Behind a New Wave of Metabolic Research
Few compounds have changed metabolic research as quickly as tirzepatide. In just a few years it has become one of the most studied peptides in the world. This article explains what it is, how it works and why researchers are so interested in it.
What is tirzepatide?
Tirzepatide is a 39-amino-acid synthetic peptide. It is known as a dual agonist because it activates two hormone receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Both are incretin hormones, released by the gut after eating to help control blood sugar and appetite.
Earlier compounds such as semaglutide target GLP-1 only. Adding GIP activity was the key step that set tirzepatide apart.
What the trials showed
Tirzepatide was studied in the large SURMOUNT and SURPASS clinical trial programmes. In SURMOUNT-1, participants on the highest dose lost an average of about 20% of body weight over 72 weeks, well ahead of earlier GLP-1-only treatments. These results pushed researchers to look at combining hormone targets, which led to triple agonists such as retatrutide.
Why it is half-life engineered
Natural incretin hormones break down within minutes. Tirzepatide has a fatty acid chain attached that binds to albumin in the blood, extending its half-life to around five days. This is why it is studied on a once-weekly schedule.
Tirzepatide in the laboratory
In research settings, tirzepatide is supplied as a lyophilised (freeze-dried) powder and reconstituted with bacteriostatic water. Vial size affects concentration and cost per milligram, so labs often choose between 10mg, 20mg and 30mg vials depending on how much the study needs.
Quality is essential. Labs should only use batches with independent HPLC purity and mass spectrometry identity results. UK laboratories can source tirzepatide 20mg research vials from suppliers that publish third-party certificates for each batch.
Conclusion
Tirzepatide showed that targeting two hormone receptors can outperform targeting one, and that idea is now shaping the next generation of metabolic research. It remains one of the most important peptides for researchers to understand.
This article is for general information only. Research peptides are sold for laboratory research use only and are not for human consumption.
